2 min read
Operationalizing Adaptive Design for FDA's One-Trial Era
Operationalizing Adaptive Design for FDA's One-Trial Era
October 20, 2026 : 11:00 AM ET
On February 18, 2026, the FDA...
Current advances in RNA-based therapies hold substantial promise in treating and preventing many human diseases and disorders through curing the disease, rather than treating the symptomology like traditional therapeutics.
While many RNA therapeutics have made it to clinical trials, only a few have been approved. Veristat’s team of scientific-minded experts
have worked on over 60 RNA programs, including several approved
therapies. Our experience expands across the clinical development pathway in a broad range of therapeutic areas.
Meet Veristat. Learn More.
2 min read
Sep 22, 2026 Veristat Events
On February 18, 2026, the FDA...
2 min read
Aug 26, 2026 Veristat Events